Iridex Corp SEC filings IRIX
Iridex Corp has 1,000 filings in SEC EDGAR's recent list, going back to Oct 5, 2007. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Jan 3, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 18, 2026, covering the quarter ended Jul 4, 2026. The most recent current report (Form 8-K) was filed on Sep 2, 2026 (listing notice). The company's fiscal year ends on January 3.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 12, 2026 |
| DEFA14A | Additional proxy material | Jun 2, 2025 | — |
| DEFA14A | Additional proxy material | May 20, 2025 | — |
| DEFA14A | Additional proxy material | May 20, 2025 | — |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 11, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2025 | Apr 17, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 18, 2024 |
| DEFA14A | Additional proxy material | May 24, 2023 | — |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 14, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 7, 2023 | Apr 7, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 15, 2022 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| DEFA14A | Additional proxy material | Apr 27, 2020 | — |
| DEF 14A | Proxy statement | Apr 27, 2020 | Jun 24, 2020 |
| DEFA14A | Additional proxy material | Jun 12, 2019 | — |
| DEF 14A | Proxy statement | Jun 12, 2019 | Jul 23, 2019 |
| DEFA14A | Additional proxy material | Apr 27, 2018 | — |
| DEF 14A | Proxy statement | Apr 27, 2018 | Jun 13, 2018 |
| DEFA14A | Additional proxy material | Apr 28, 2017 | — |
| DEF 14A | Proxy statement | Apr 28, 2017 | Jun 14, 2017 |
| DEFA14A | Additional proxy material | Apr 29, 2016 | — |
| DEF 14A | Proxy statement | Apr 29, 2016 | Jun 15, 2016 |
| DEFA14A | Additional proxy material | May 1, 2015 | — |
| DEF 14A | Proxy statement | May 1, 2015 | Jun 17, 2015 |
| DEF 14A | Proxy statement | Apr 25, 2014 | Jun 11, 2014 |
| DEF 14A | Proxy statement | Apr 26, 2013 | Jun 12, 2013 |
| DEF 14A | Proxy statement | Apr 27, 2012 | Jun 13, 2012 |
| DEF 14A | Proxy statement | Apr 29, 2011 | Jun 15, 2011 |
| DEF 14A | Proxy statement | May 7, 2010 | Jun 16, 2010 |
| DEF 14A | Proxy statement | May 4, 2009 | Jun 17, 2009 |
| DEF 14A | Proxy statement | Apr 28, 2008 | Jun 11, 2008 |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- IRIX (Nasdaq)
- Fiscal year ends
- January 3
- Incorporated in
- DE
- Headquarters
- Mountain View, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1006045
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.